The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis
Open accessAbstract
Non-phagocytic eukaryotic cells can internalize particles <1 µm in size, encompassing pathogens, liposomes for drug delivery or lipoplexes applied in gene delivery. In the present study, we have investigated the effect of particle size on the pathway of entry and subsequent intracellular fate in non-phagocytic B16 cells, using a range of fluorescent latex beads of defined sizes (50–1000 nm). Our data reveal that particles as large as 500 nm were internalized by cells via an energy-dependent process. With an increase in size (50–500 nm), cholesterol depletion increased the efficiency of inhibition of uptake. The processing of the smaller particles was significantly perturbed upon microtubule disruption, while displaying a negligible effect on that of the 500 nm beads. Inhibitor and co-localization studies revealed that the mechanism by which the beads were internalized, and their subsequent intracellular routing, was strongly dependent on particle size. Internalization of microspheres with a diameter <200 nm involved clathrin-coated pits. With increasing size, a shift to a mechanism that relied on caveolae-mediated internalization became apparent, which became the predominant pathway of entry for particles of 500 nm in size. At these conditions, delivery to the lysosomes was no longer apparent. The data indicate that the size itself of (ligand-devoid) particles can determine the pathway of entry. The clathrin-mediated pathway of endocytosis shows an upper size limit for internalization of approx. 200 nm, and kinetic parameters may determine the almost exclusive internalization of such particles along this pathway rather than via caveolae.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure.
Felgner, P. L., Gadek, T. R., Holm, M., Roman, R., Chan, H. W., Wenz, M., Northrop, J. P., Ringold, G. M., & Danielsen, M. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7413 · Cited by 4,978
Srimaroeng, C., Cecile, J. P., Walden, R., & Pritchard, J. B. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350077 · Cited by 2,989
Caveolin, a protein component of caveolae membrane coats
Rothberg, K. G., Heuser, J. E., Donzell, W. C., Ying, Y.-S., Glenney, J. R., & Anderson, R. G. W. (1992) · Cell · doi:10.1016/0092-8674(92)90143-z · Cited by 2,258
Cellular and Molecular Barriers to Gene Transfer by a Cationic Lipid
Zabner, J., Fasbender, A. J., Moninger, T., Poellinger, K. A., & Welsh, M. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.32.18997 · Cited by 1,410
Mis-assembly of clathrin lattices on endosomes reveals a regulatory switch for coated pit formation.
Wang, L. H., Rothberg, K. G., & Anderson, R. G. (1993) · The Journal of cell biology · doi:10.1083/jcb.123.5.1107 · Cited by 1,177
Mechanism of DNA Release from Cationic Liposome/DNA Complexes Used in Cell Transfection,
Xu, Y., & Szoka, F. C. (1996) · Biochemistry · doi:10.1021/bi9602019 · Cited by 1,134
Rodal, S. K., Skretting, G., Garred, Ø., Vilhardt, F., van Deurs, B., & Sandvig, K. (1999) · Molecular Biology of the Cell · doi:10.1091/mbc.10.4.961 · Cited by 1,008
Schnitzer, J. E., Oh, P., Pinney, E., & Allard, J. (1994) · The Journal of cell biology · doi:10.1083/jcb.127.5.1217 · Cited by 919
Cellular Cholesterol Efflux Mediated by Cyclodextrins
Kilsdonk, E. P. C., Yancey, P. G., Stoudt, G. W., Bangerter, F. W., Johnson, W. J., Phillips, M. C., & Rothblat, G. H. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.29.17250 · Cited by 890
Tracking the intracellular path of poly(ethylenimine)/DNA complexes for gene delivery
Godbey, W. T., Wu, K. K., & Mikos, A. G. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.9.5177 · Cited by 822
Cited by
Items 101–193 of 193
Mesoporous silica nanoparticles as nanocarriers
Wu, S.-H., Hung, Y., & Mou, C.-Y. (2011) · Chemical Communications · doi:10.1039/c1cc11760b · Cited by 372
Polymeric Delivery of Therapeutic Nucleic Acids
Kumar, R., Santa Chalarca, C. F., Bockman, M. R., Bruggen, C. V., Grimme, C. J., Dalal, R. J., Hanson, M. G., Hexum, J. K., & Reineke, T. M. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00997 · Cited by 365
Update on Macrophage Clearance of Inhaled Micro- and Nanoparticles
Geiser, M. (2010) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2009.0797 · Cited by 365
Uptake and intracellular distribution of silver nanoparticles in human mesenchymal stem cells
Greulich, C., Diendorf, J., Simon, T., Eggeler, G., Epple, M., & Köller, M. (2011) · Acta Biomaterialia · doi:10.1016/j.actbio.2010.08.003 · Cited by 363
Nanovehicular Intracellular Delivery Systems
Prokop, A., & Davidson, J. M. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21270 · Cited by 363
Wang, T., Bai, J., Jiang, X., & Nienhaus, G. U. (2012) · ACS Nano · doi:10.1021/nn203892h · Cited by 362
New views on cellular uptake and trafficking of manufactured nanoparticles
Treuel, L., Jiang, X., & Nienhaus, G. U. (2013) · Journal of The Royal Society Interface · doi:10.1098/rsif.2012.0939 · Cited by 362
Size-dependent toxicity and cell interaction mechanisms of gold nanoparticles on mouse fibroblasts
Coradeghini, R., Gioria, S., García, C. P., Nativo, P., Franchini, F., Gilliland, D., Ponti, J., & Rossi, F. (2013) · Toxicology Letters · doi:10.1016/j.toxlet.2012.11.022 · Cited by 359
Clift, M. J. D., Rothen-Rutishauser, B., Brown, D. M., Duffin, R., Donaldson, K., Proudfoot, L., Guy, K., & Stone, V. (2008) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2008.06.009 · Cited by 358
Brandenberger, C., Mühlfeld, C., Ali, Z., Lenz, A., Schmid, O., Parak, W. J., Gehr, P., & Rothen‐Rutishauser, B. (2010) · Small · doi:10.1002/smll.201000528 · Cited by 355
Artificial viruses: a nanotechnological approach to gene delivery
Mastrobattista, E., van der Aa, M. A. E. M., Hennink, W. E., & Crommelin, D. J. A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1960 · Cited by 346
Intracellular trafficking of nonviral vectors
Medina-Kauwe, L. K., Xie, J., & Hamm-Alvarez, S. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302592 · Cited by 346
Endocytosis of Gene Delivery Vectors: From Clathrin-dependent to Lipid Raft-mediated Endocytosis
El-Sayed, A., & Harashima, H. (2013) · Molecular Therapy · doi:10.1038/mt.2013.54 · Cited by 345
Toxicity of Nanomaterials: Exposure, Pathways, Assessment, and Recent Advances
Ganguly, P., Breen, A., & Pillai, S. C. (2018) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.8b00068 · Cited by 341
Barriers to drug delivery in solid tumors
Sriraman, S. K., Aryasomayajula, B., & Torchilin, V. P. (2014) · Tissue Barriers · doi:10.4161/tisb.29528 · Cited by 338
Understanding nanoparticle cellular entry: A physicochemical perspective
Beddoes, C. M., Case, C. P., & Briscoe, W. H. (2015) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2015.01.007 · Cited by 336
Layer‐By‐Layer‐Assembled Capsules and Films for Therapeutic Delivery
Becker, A. L., Johnston, A. P. R., & Caruso, F. (2010) · Small · doi:10.1002/smll.201000379 · Cited by 336
Glycopolymer probes of signal transduction
Kiessling, L. L., & Grim, J. C. (2013) · Chemical Society Reviews · doi:10.1039/c3cs60097a · Cited by 335
Bimbo, L. M., Sarparanta, M., Santos, H. A., Airaksinen, A. J., Mäkilä, E., Laaksonen, T., Peltonen, L., Lehto, V.-P., Hirvonen, J., & Salonen, J. (2010) · ACS Nano · doi:10.1021/nn901657w · Cited by 335
Salvati, A., Åberg, C., dos Santos, T., Varela, J., Pinto, P., Lynch, I., & Dawson, K. A. (2011) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2011.03.005 · Cited by 333
Duncan, R., & Richardson, S. C. W. (2012) · Molecular Pharmaceutics · doi:10.1021/mp300293n · Cited by 332
Teplensky, M. H., Fantham, M., Li, P., Wang, T. C., Mehta, J. P., Young, L. J., Moghadam, P. Z., Hupp, J. T., Farha, O. K., Kaminski, C. F., et al. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.7b01451 · Cited by 332
Polymeric Nanoparticles for Delivery of Natural Bioactive Agents: Recent Advances and Challenges
Elmowafy, M., Shalaby, K., Elkomy, M. H., Alsaidan, O. A., Gomaa, H. A. M., Abdelgawad, M. A., & Mostafa, E. M. (2023) · Polymers · doi:10.3390/polym15051123 · Cited by 332
Ahmed, F., Pakunlu, R. I., Srinivas, G., Brannan, A., Bates, F., Klein, M. L., Minko, T., & Discher, D. E. (2006) · Molecular Pharmaceutics · doi:10.1021/mp050103u · Cited by 330
Effect of Physico-Chemical Properties of Nanoparticles on Their Intracellular Uptake
Sabourian, P., Yazdani, G., Ashraf, S. S., Frounchi, M., Mashayekhan, S., Kiani, S., & Kakkar, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218019 · Cited by 329
Lipoplex morphologies and their influences on transfection efficiency in gene delivery
Ma, B., Zhang, S., Jiang, H., Zhao, B., & Lv, H. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.08.022 · Cited by 326
Nanoparticle Geometry and Surface Orientation Influence Mode of Cellular Uptake
Herd, H., Daum, N., Jones, A. T., Huwer, H., Ghandehari, H., & Lehr, C.-M. (2013) · ACS Nano · doi:10.1021/nn304439f · Cited by 326
Roger, E., Lagarce, F., Garcion, E., & Benoit, J.-P. (2010) · Nanomedicine · doi:10.2217/nnm.09.110 · Cited by 324
In vitro and in vivo characterization of pharmaceutical nanocarriers used for drug delivery
Jain, A. K., & Thareja, S. (2019) · Artificial Cells, Nanomedicine, and Biotechnology · doi:10.1080/21691401.2018.1561457 · Cited by 319
Wang, H., Feng, Z., Wang, Y., Zhou, R., Yang, Z., & Xu, B. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.6b09783 · Cited by 315
von Gersdorff, K., Sanders, N. N., Vandenbroucke, R., De Smedt, S. C., Wagner, E., & Ogris, M. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.07.006 · Cited by 314
Lipid-Based DNA Therapeutics: Hallmarks of Non-Viral Gene Delivery
Buck, J., Grossen, P., Cullis, P. R., Huwyler, J., & Witzigmann, D. (2019) · ACS Nano · doi:10.1021/acsnano.8b07858 · Cited by 312
Yu, J., Javier, D., Yaseen, M. A., Nitin, N., Richards-Kortum, R., Anvari, B., & Wong, M. S. (2010) · Journal of the American Chemical Society · doi:10.1021/ja908139y · Cited by 312
Charge‐Reversal Drug Conjugate for Targeted Cancer Cell Nuclear Drug Delivery
Zhou, Z., Shen, Y., Tang, J., Fan, M., Van Kirk, E. A., Murdoch, W. J., & Radosz, M. (2009) · Advanced Functional Materials · doi:10.1002/adfm.200900825 · Cited by 311
Understanding and exploiting nanoparticles' intimacy with the blood vessel and blood
Setyawati, M. I., Tay, C. Y., Docter, D., Stauber, R. H., & Leong, D. T. (2015) · Chemical Society Reviews · doi:10.1039/c5cs00499c · Cited by 308
Ultrasmall inorganic nanoparticles: State-of-the-art and perspectives for biomedical applications
Zarschler, K., Rocks, L., Licciardello, N., Boselli, L., Polo, E., Garcia, K. P., De Cola, L., Stephan, H., & Dawson, K. A. (2016) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2016.02.019 · Cited by 303
Mohamed, F., & van der Walle, C. F. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21082 · Cited by 299
Health implications of nanoparticles
Kreyling, W. G., Semmler-Behnke, M., & Möller, W. (2006) · Journal of Nanoparticle Research · doi:10.1007/s11051-005-9068-z · Cited by 300
Corona Composition Can Affect the Mechanisms Cells Use to Internalize Nanoparticles
Francia, V., Yang, K., Deville, S., Reker-Smit, C., Nelissen, I., & Salvati, A. (2019) · ACS Nano · doi:10.1021/acsnano.9b03824 · Cited by 300
Drug Delivery via Cell Membrane Fusion Using Lipopeptide Modified Liposomes
Yang, J., Bahreman, A., Daudey, G., Bussmann, J., Olsthoorn, R. C. L., & Kros, A. (2016) · ACS Central Science · doi:10.1021/acscentsci.6b00172 · Cited by 299
Endo- and Exocytosis of Zwitterionic Quantum Dot Nanoparticles by Live HeLa Cells
Jiang, X., Röcker, C., Hafner, M., Brandholt, S., Dörlich, R. M., & Nienhaus, G. U. (2010) · ACS Nano · doi:10.1021/nn101277w · Cited by 299
Nanotechnological carriers for cancer chemotherapy: The state of the art
Estanqueiro, M., Amaral, M. H., Conceição, J., & Sousa Lobo, J. M. (2015) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2014.12.041 · Cited by 298
Uptake Mechanism of Oppositely Charged Fluorescent Nanoparticles in HeLa Cells
Dausend, J., Musyanovych, A., Dass, M., Walther, P., Schrezenmeier, H., Landfester, K., & Mailänder, V. (2008) · Macromolecular Bioscience · doi:10.1002/mabi.200800123 · Cited by 297
PRINT: A Novel Platform Toward Shape and Size Specific Nanoparticle Theranostics
Perry, J. L., Herlihy, K. P., Napier, M. E., & DeSimone, J. M. (2011) · Accounts of Chemical Research · doi:10.1021/ar2000315 · Cited by 290
Cationic liposomes for gene delivery
Simões, S., Filipe, A., Faneca, H., Mano, M., Penacho, N., Düzgünes, N., & Pedroso de Lima, M. (2005) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2.2.237 · Cited by 285
Uptake mechanisms of non-viral gene delivery
Xiang, S., Tong, H., Shi, Q., Fernandes, J. C., Jin, T., Dai, K., & Zhang, X. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.09.093 · Cited by 284
Kanchan, V., & Panda, A. K. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.08.015 · Cited by 283
Size-dependent cellular uptake and localization profiles of silver nanoparticles
Wu, M., Guo, H., Liu, L., Liu, Y., & Xie, L. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s201107 · Cited by 282
Li, Y., Chen, X., & Gu, N. (2008) · The Journal of Physical Chemistry B · doi:10.1021/jp8051906 · Cited by 282
Zeng, X., Tao, W., Mei, L., Huang, L., Tan, C., & Feng, S.-S. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.04.052 · Cited by 282
Design considerations for nanotherapeutics in oncology
Stylianopoulos, T., & Jain, R. K. (2015) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2015.07.015 · Cited by 280
Subchronic and chronic toxicity evaluation of inorganic nanoparticles for delivery applications
Mohammadpour, R., Dobrovolskaia, M. A., Cheney, D. L., Greish, K. F., & Ghandehari, H. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.07.006 · Cited by 280
Pearce, A. K., & O’Reilly, R. K. (2019) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.9b00456 · Cited by 275
Quantitative Assessment of the Comparative Nanoparticle‐Uptake Efficiency of a Range of Cell Lines
dos Santos, T., Varela, J., Lynch, I., Salvati, A., & Dawson, K. A. (2011) · Small · doi:10.1002/smll.201101076 · Cited by 273
Yoo, J.-W., Doshi, N., & Mitragotri, S. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.05.004 · Cited by 272
Fischer, R., Fotin‐Mleczek, M., Hufnagel, H., & Brock, R. (2005) · ChemBioChem · doi:10.1002/cbic.200500044 · Cited by 269
Health impact and safety of engineered nanomaterials
Teow, Y., Asharani, P. V., Hande, M. P., & Valiyaveettil, S. (2011) · Chemical Communications · doi:10.1039/c0cc05271j · Cited by 269
Wang, T., Upponi, J. R., & Torchilin, V. P. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.07.013 · Cited by 268
Zhang, W., Hong, C., & Pan, C. (2019) · Macromolecular Rapid Communications · doi:10.1002/marc.201800279 · Cited by 265
Intracellular trafficking pathways and drug delivery: fluorescence imaging of living and fixed cells
WATSON, P. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.05.003 · Cited by 265
Lai, S. K., Hida, K., Man, S. T., Chen, C., Machamer, C., Schroer, T. A., & Hanes, J. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.02.021 · Cited by 264
Effect of mechanical properties of hydrogel nanoparticles on macrophage cell uptake
Banquy, X., Suarez, F., Argaw, A., Rabanel, J.-M., Grutter, P., Bouchard, J.-F., Hildgen, P., & Giasson, S. (2009) · Soft Matter · doi:10.1039/b821583a · Cited by 261
Magnetic targeting for site-specific drug delivery: applications and clinical potential
Polyak, B., & Friedman, G. (2009) · Expert Opinion on Drug Delivery · doi:10.1517/17425240802662795 · Cited by 260
Matrices and scaffolds for DNA delivery in tissue engineering
De Laporte, L., & Shea, L. D. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.03.017 · Cited by 258
Jeong, S.-H., Jang, J.-H., & Lee, Y.-B. (2023) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-022-00589-5 · Cited by 256
Drug delivery of siRNA therapeutics: potentials and limits of nanosystems
Reischl, D., & Zimmer, A. (2009) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2008.06.001 · Cited by 253
Quantum dot-based theranostics
Ho, Y.-P., & Leong, K. W. (2010) · Nanoscale · doi:10.1039/b9nr00178f · Cited by 253
Critical evaluation of biodegradable polymers used in nanodrugs
Caballero-George, C., Marin, & Briceño (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s47186 · Cited by 252
Kreyling, W. G., Hirn, S., Möller, W., Schleh, C., Wenk, A., Celik, G., Lipka, J., Schäffler, M., Haberl, N., Johnston, B. D., et al. (2014) · ACS Nano · doi:10.1021/nn403256v · Cited by 243
Block copolymer micelles as delivery vehicles of hydrophobic drugs: Micelle–cell interactions
Savić, R., Eisenberg, A., & Maysinger, D. (2006) · Journal of Drug Targeting · doi:10.1080/10611860600874538 · Cited by 218
Ritzel, R. M., Doran, S. J., Glaser, E. P., Meadows, V. E., Faden, A. I., Stoica, B. A., & Loane, D. J. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.02.010 · Cited by 156
Fate of micelles and quantum dots in cells
Maysinger, D., Lovrić, J., Eisenberg, A., & Savić, R. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2006.08.011 · Cited by 160
Delivery of mRNA Therapeutics for the Treatment of Hepatic Diseases
Trepotec, Z., Lichtenegger, E., Plank, C., Aneja, M. K., & Rudolph, C. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2018.12.012 · Cited by 115
Nanoplastic Toxicity: Insights and Challenges from Experimental Model Systems
Schröter, L., & Ventura, N. (2022) · Small · doi:10.1002/smll.202201680 · Cited by 99
Nagai, H., & Toyokuni, S. (2012) · Cancer Science · doi:10.1111/j.1349-7006.2012.02326.x · Cited by 98
Li, Z., & Gu, L. (2014) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf404621f · Cited by 96
Chen, T., Li, C., Li, Y., Yi, X., Wang, R., Lee, S. M.-Y., & Zheng, Y. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b01171 · Cited by 89
Direct cellular delivery of human proteasomes to delay tau aggregation
Han, D. H., Na, H.-K., Choi, W. H., Lee, J. H., Kim, Y. K., Won, C., Lee, S.-H., Kim, K. P., Kuret, J., Min, D.-H., et al. (2014) · Nature Communications · doi:10.1038/ncomms6633 · Cited by 88
Mechanisms of uptake and transport of particulate formulations in the small intestine
Delon, L., Gibson, R. J., Prestidge, C. A., & Thierry, B. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.02.006 · Cited by 64
Moore, N. M., Sheppard, C. L., Barbour, T. R., & Sakiyama‐Elbert, S. E. (2008) · The Journal of Gene Medicine · doi:10.1002/jgm.1234 · Cited by 63
Protein Corona Formation on Lipid Nanoparticles Negatively Affects the NLRP3 Inflammasome Activation
Debnath, M., Forster, J., Ramesh, A., & Kulkarni, A. (2023) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.3c00329 · Cited by 60
Intraventricular Delivery of siRNA Nanoparticles to the Central Nervous System
Shyam, R., Ren, Y., Lee, J., Braunstein, K. E., Mao, H.-Q., & Wong, P. C. (2015) · Molecular Therapy - Nucleic Acids · doi:10.1038/mtna.2015.15 · Cited by 58
Villate-Beitia, I., Gallego, I., Martínez-Navarrete, G., Zárate, J., López-Méndez, T., Soto-Sánchez, C., Santos-Vizcaíno, E., Puras, G., Fernández, E., & Pedraz, J. L. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.07.035 · Cited by 42
Garcia-Pinel, B., Jabalera, Y., Ortiz, R., Cabeza, L., Jimenez-Lopez, C., Melguizo, C., & Prados, J. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12060589 · Cited by 40
Alami-Milani, M., Zakeri-Milani, P., Valizadeh, H., Fathi, M., Salatin, S., Salehi, R., & Jelvehgari, M. (2020) · Pharmaceutical Development and Technology · doi:10.1080/10837450.2020.1733606 · Cited by 36
Refining in vitro models for nanomaterial exposure to cells and tissues
Guggenheim, E. J., Milani, S., Röttgermann, P. J. F., Dusinska, M., Saout, C., Salvati, A., Rädler, J. O., & Lynch, I. (2018) · NanoImpact · doi:10.1016/j.impact.2018.02.008 · Cited by 36
Kang, T., Park, C., & Lee, B.-J. (2016) · Archives of Pharmacal Research · doi:10.1007/s12272-016-0847-0 · Cited by 35
Extracellular vesicles and lipoproteins – Smart messengers of blood cells in the circulation
Nguyen, P. H. D., Le, A. H., Pek, J. S. Q., Pham, T. T., Jayasinghe, M. K., Do, D. V., Phung, C. D., & Le, M. T. N. (2022) · Journal of Extracellular Biology · doi:10.1002/jex2.49 · Cited by 31
Veernala, I., Giri, J., Pradhan, A., Polley, P., Singh, R., & Yadava, S. K. (2019) · Scientific Reports · doi:10.1038/s41598-018-37327-7 · Cited by 27
Guo, C., Weber, R. J. M., Buckley, A., Mazzolini, J., Robertson, S., Delgado-Saborit, J. M., Rappoport, J. Z., Warren, J., Hodgson, A., Sanderson, P., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020556 · Cited by 25
Singh, T., Kang, D. H., Kim, T. W., Kong, H. J., Ryu, J. S., Jeon, S., Ahn, T. S., Jeong, D., Baek, M. J., & Im, J. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120904 · Cited by 26
Nuclear proteins as gene-transfer vectors
Haberland, A., & Böttger, M. (2005) · Biotechnology and Applied Biochemistry · doi:10.1042/ba20050063 · Cited by 24
Biocompatibility and toxicity challenges of nanomaterials
Yaşayan, G., Alarcin, E., Avci-Adali, M., Ipek, T. C., Nejati, O., Özcan-Bülbül, E., Karslı, S., Bal-Öztürk, A., & Mostafavi, E. (2024) · Functionalized Nanomaterials for Cancer Research · doi:10.1016/b978-0-443-15518-5.00019-7 · Cited by 8
Metadata
- Authors
- REJMAN, J., OBERLE, V., ZUHORN, I. S., & HOEKSTRA, D.
- Venue
- Biochemical Journal
- Publisher
- Portland Press Ltd.
- Published
- 2004-01-01
- Volume
- 377
- Issue
- 1
- Pages
- 159-169
- ISSN
- 0264-6021 (ISSN-L)
- 1470-8728
- OpenAlex
- W2113972541
- Cited by
- 2,864
- References
- 45
- FWCI
- 20.30
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.